🔎 Trials Near Me

Beranda › Melanoma › Ohio › Columbus

Uji klinis Melanoma di Columbus, OH

21 studi untuk Melanoma mencari peserta di lokasi sekitar Columbus (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • dan 8 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Menerima pesertaFase 3
  • The Ohio State University Wexner Medical Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Menerima pesertaFase 3
  • Ohio State University, Columbus
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Menerima pesertaFase 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Menerima pesertaFase 1
  • Ohio State University, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06529822

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Menerima pesertaFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • dan 15 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Nationwide Children's Hospital, Columbus
  • Ohio State University Comprehensive Cancer Center, Columbus
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Menerima pesertaFase 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT04697576

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

Menerima pesertaFase 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05588453

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Menerima pesertaFase 1/2
  • Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Menerima pesertaFase 3
  • Ohio State Eye and Ear Institute, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Menerima pesertaFase 2/3
  • The Ohio State University, Columbus
Semua usia · Semua jenis kelamin · Diperbarui 2 Apr 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Memorial Hospital, Marysville · 27 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

Menerima pesertaFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06223659

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • The Ohio State University Wexner Medical Center, Columbus
Semua usia · Semua jenis kelamin · Diperbarui 9 Mar 2026 · NCT04792463

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Menerima pesertaFase 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT05549297

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Ohio State University Comprehensive Cancer Center, Columbus
Semua usia · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT04567706

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Menerima pesertaFase 3
  • Ohio State University Wexner Medical Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Des 2025 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Columbus
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Menerima peserta
  • Ohio State University Comprehensive Cancer Center, Columbus
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883

Uji klinis Melanoma di kota lain

Studi lain di Columbus

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.